ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
0,00%
(0,00) 1K
13-noy, 17:35:01 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALMKT tikeri uchun statistika yaratilmoqda...
Ochish
0,09 €
Yuqori
0,10 €
Past
0,09 €
Bozor kapitali
18,14Â mln
Oʻrtacha hajm
541,14Â ming
Hajmi
75,16Â ming
P/E koeffitsiyenti
0,79
52 haftalik eng yuqori
0,23 €
52 haftalik eng past
0,07 €
Aksiya boʻyicha daromad
0,12 €
Muomaladagi aksiyalar
195,26Â mln
Xodimlar soni
56
Ochish
0,09 €
Yuqori
0,10 €
Past
0,09 €
Bozor kapitali
18,14Â mln
Oʻrtacha hajm
541,14Â ming
Hajmi
75,16Â ming
P/E koeffitsiyenti
0,79
52 haftalik eng yuqori
0,23 €
52 haftalik eng past
0,07 €
Aksiya boʻyicha daromad
0,12 €
Muomaladagi aksiyalar
195,26Â mln
Xodimlar soni
56
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TradingView
·
46 daqiqa oldin
SpaceX's S&P 500 bid gets new life as Elon Musk pitches Tesla merger
Benzinga
·
50 daqiqa oldin
S&P 500 Rout Exposes Hidden Risk In 10% Buffered ETFs
The Motley Fool
·
4 soat oldin
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
Traders Union
·
45 daqiqa oldin
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA haqida
CEOSacha Loiseau
Xodimlar soni56
Asos solingan2000
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytmaunakeatech.com